Resumen

BELTRAN, Brady E.; RAMOS, Willy  y  DE LA CRUZ-VARGAS, Jhony A.. Index lymphocyte/monocite as a pronosis factor in lymphoma large cells diffuse, Edgardo Rebagliati Martins Hospital 2010-2017. Rev. Fac. Med. Hum. [online]. 2019, vol.19, n.2, pp.40-47. ISSN 1814-5469.  http://dx.doi.org/10.25176/RFMH.v19.n2.2068.

Objetive: To evaluate the prognostic value of the monocyte lymphocyte index (ILM) in the overall survival of patients with diffuse large B-cell lymphoma (LCGBD) of the Edgardo Rebagliati Martins Hospital. Methods: Retrospective longitudinal study. We included cases of LCGBD diagnosed in the National Hospital Edgardo Rebagliati Martins during the period 2010-2017. No sampling was done, we worked with the entire population that met the selection criteria because it is small and accessible. The patients' clinical histories were reviewed, obtaining information about the time in months of survival, ILM, as well as sociodemographic, clinical and laboratory variables. Results: 121 patients with LCGBD were included in the analysis; of them, 57% were female and 66.1% were older than 60 years. According to the Zubrod Status, 66.5% corresponded to the degree of better prognosis and 59.5% presented associated B symptoms. About 60% were diagnosed in stages I and II and 57% presented extranodal involvement. The bivariate analysis with the Cox proportional hazards model showed that the ILM <2 constituted a predictor of the overall survival of the LCGBD (p = 0.011), estimating HR = 2.2 (95% CI: 1.2-4.1); likewise, an ILM <1.7 was also a predictor (p = 0.009) with an estimated HR = 2.2 (95% CI: 1.2-4.1). ILM <2.7 was not a predictor of overall survival.. Conclusion: The ILM could be used as a prognostic index because it is a predictor of the overall survival of patients with LCGBD of the Edgardo Rebagliati Martins National Hospital.

Palabras clave : Large Diffuse B-Cell Lymphoma; Forecast; Survival.

        · resumen en Español     · texto en Español     · Español ( pdf ) | Inglés ( pdf )